Аnalysis of transpapillary interventions complications
Abstract The results of 1028 endoscopic procedures have transpapillary 575 patients with benign and malignant pathology pancreatobiliary area. Postmanipulаtion complications occurred in 31 cases and amounted to 2.9% of mortality 1 (0.09%). Analysis of complications was conducted in the period of activity in view of the introduction of the most important preventive and therapeutic measures. The complex of prophylactic and therapeutic measures will reduce the number of complications from 8.5% in 2007–2008 to 1.2% in 2014–2015. Leading events affecting the security of transpapillary interventions were: experience of the doctor, the inclusion in the preoperative diagnostic algorithm endosonography, stenting bile and the main pancreatic ducts, reduction of the duration of surgery and increase the number of phases of the operation.
Keywords:postmanipulyatsionnye complications transpapillary intervention, preventive and therapeutic measures
Clin. Experiment. Surg. Petrovsky J. 2015. № 3. Р. 51–56.
References
1. Deryabin E.A., Bratnikova G.I., Vasiliev A.V. Improving the safety of therapeutic endoscopic retrograde cholangiopancreatography in patients with benign obstructive biliary tract diseases. Meditsinskaya vizualizatsiya [Medical Visualization]. 2010; Vol. 2: 73–80. (in Russian)
2. Kotovsky A.E., Glebov K.G., Uruzhumtseva G.A. et al. Endoscopic techniques in the treatment of diseases of the area hepatopancreatoduodenal. Annaly khirurgicheskoy gepatologii [Annals of Surgical Hepatology]. 2010; Vol. 1: 9–18. (in Russian)
3. Jeurnink S.M., Siersema P.D., Steyerberg E.W. Predictors of complications after endoscopic retrograde cholangiopancreatography: a prognostic model for early discharge. Surg Endosc. 2011; Vol. 25, N 9: 2892–900.
4. Costamagna G., Tringali A., Shah S. K., et al. Long-term follow-up of patients after endoscopic sphincterotomy for choledocholithiasis, and risk factors for recurrence. Endoscopy. 2002; Vol. 34, N 4: 273–9.
5. M.P. Mantserov, Ye.V. Moroz Secondary pancreatitis after endoscopic manipulations on the major duodenal papilla. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii [Russian Journal of Gastroenterology, Hepatology, Coloproctology]. 2007; Vol. 3: 14–23. (in Russian)
6. Freeman M.L., DiSario J.A., Nelson D.B. et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study// Gastroin- test. Endosc. 2001; Vol. 54. P. 425–434.
7. Masci E., Mariani A., Curioni S., Testoni P.A. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 2003. Vol. 35, N 10. P. 830–834.
8. Galperin E. I. Guidance on surgery of the biliary tract. Moscow: Vidar, 2009. 568 р. (in Russian)
9. Kahaleh М., Freeman М. Prevention and management of post-endoscopic retrograde cholangiopancreatography complications. Clin Endosc. 2012; Vol. 45: 305–12.
10. Revyakin V.I., Vasilenko K.V. Methods of elimination of Dormia’s basket impaction in bile ducts. Endoskopicheskaya khirurgiya [Endoscopic Surgery]. 2010; Vol. 4: 30–3 (in Russian)
11. Burdukov M.S. Diagnostic and therapeutic endoscopy in the tumors of biliopancreaticoduodenal zone. Autoabstract of Diss. Moscow, 2010. 30 р. (in Russian)
12. Anderson M.A., Fisher L., Jain R. et al. Complications of ERCP. ASGE Standards of Practice Committee. Gastrointest Endosc. 2012; Vol. 75, N 3: 467–73.
13. Dumonceau J.M., Andriulli A., Deviere J., et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy. 2010; Vol. 42, N 6: 503–15.
14. Tsuchiya T., Itoi T., Sofuni A., et al. Тemporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial. J Hepatobiliary Pancreat Surg. 2007; Vol. 14: 302–7.
15. Kawaguchi Y., Ogawa M., Omata F. et al. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography. World J. Gastroenterol. 2012; Vol. 18, N 14: 1635–41.
16. Elmunzer B.J., Scheiman J.M., Lehman G.A., et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N. Engl. J. Med. 2012; Vol. 366: 1414–22.
17. Lazaraki G. Prevention of post ERCP pancreatitis: an overview. Ann Gastroenterol. 2008; Vol. 21, N 1: 27–38.